SanyouBio announced today the official launch of 73 whole-series bispecific antibody reference products, covering globally approved and representative clinical-stage bispecific antibody drugs. The ...
Does a claim that merely recites an inherent property of an otherwise obvious claim require an additional analysis to demonstrate that a person ...
EpimAb_LogoPlanegg/Martinsried and Shanghai, February 27, 2025. Medigene AG (Medigene, FSE: MDG1, Prime Standard) and EpimAb Biotherapeutics, ...
DEVASTATED Nadia Sawalha fought back tears in an emotional video as she shared some heartbreaking news. Loose Women star ...
The multi-target collaboration combines the respective expertise of each company with Medigene’s 3S (sensitive, specific and safe) TCR generation and characterization capabilities and EpimAb’s ...
Pharmaceutical Technology on MSN16d
Medigene and EpimAb to develop T cell engagers for solid tumoursMedigene and EpimAb Biotherapeutics have signed a co-development agreement involving T cell receptor (TCR)-guided T cell ...
Robust, Consistent Phase 3 Data and Real-World Evidence Outcomes Support ANX005 as Potential First Targeted Therapy for GBS; Pre-BLA Meeting ...
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday said that its investment plan in Arizona is going according to schedule, following a local media report claiming that the company is ...
Not long after the first flu shot was introduced in 1945 by University of Michigan virologist Thomas Francis and his ...
Share on Pinterest Scientists have found that an antibody treatment prevented a decline in muscle mass and bone density after using GLP-1 drugs. Rob and Julia Campbell/Stocksy Aging and limited ...
The antigen-binding site of the antibody has a unique structure that allows it to bind antigen in a highly specific manner. Functional and structural studies of two potent antibodies isolated from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback